|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2800 CAD | +3.70% |
|
0.00% | +9.80% |
| 11-20 | Vext Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 | CI |
| 11-20 | Vext Science, Inc., Q3 2025 Earnings Call, Nov 20, 2025 |
Company Valuation: Vext Science, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 89.47 | 69.14 | 26.42 | 47.76 | 28.38 | 50.71 | 50.71 | - |
| Change | - | -22.72% | -61.79% | 80.79% | -40.58% | 78.7% | 0% | - |
| Enterprise Value (EV) 1 | 89.47 | 76.78 | 58.63 | 77.63 | 63.27 | 81.41 | 76.71 | 50.71 |
| Change | - | -14.19% | -23.63% | 32.4% | -18.51% | 28.67% | -5.77% | -33.9% |
| P/E ratio | 39.5x | - | - | 7.07x | -1.43x | -4.06x | -6.67x | - |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | - | - | - | 0x | 0.1x | 0.2x | - |
| Capitalization / Revenue | 3.55x | 1.86x | 0.75x | 1.37x | 0.79x | 0.98x | 0.85x | 0.69x |
| EV / Revenue | 3.55x | 2.06x | 1.66x | 2.23x | 1.76x | 1.58x | 1.29x | 0.69x |
| EV / EBITDA | 13.1x | 5.73x | 3.88x | 14x | 6.91x | 6.62x | 3.65x | - |
| EV / EBIT | - | - | - | - | - | - | - | - |
| EV / FCF | -9.13x | -10.8x | -20x | 46x | 34.7x | 12.2x | 13.2x | - |
| FCF Yield | -11% | -9.25% | -5.01% | 2.17% | 2.88% | 8.23% | 7.56% | - |
| Dividend per Share 3 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 3 | 0.0251 | - | - | 0.041 | -0.115 | -0.069 | -0.042 | - |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 25.19 | 37.24 | 35.41 | 34.81 | 36 | 51.5 | 59.57 | 73.48 |
| EBITDA 1 | 6.813 | 13.39 | 15.12 | 5.528 | 9.153 | 12.3 | 21 | - |
| EBIT | 4.686 | - | - | -7.843 | -11.18 | - | - | - |
| Net income 1 | 2.125 | - | - | - | - | -11.63 | -6.211 | 0.7469 |
| Net Debt 1 | - | 7.635 | 32.22 | 29.88 | 34.89 | 30.7 | 26 | - |
| Reference price 3 | 0.9900 | 0.6400 | 0.2400 | 0.2900 | 0.1650 | 0.2800 | 0.2800 | 0.2800 |
| Nbr of stocks (in thousands) | 115,153 | 136,713 | 148,963 | 217,484 | 247,443 | 251,034 | 251,034 | - |
| Announcement Date | 15/04/21 | 20/04/22 | 22/03/23 | 10/05/24 | 31/03/25 | - | - | - |
1CAD in Million2USD in Million3CAD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.91x | 1.54x | 6.46x | - | 50.71M | |
| 164.22x | - | - | - | 211M | |
| -1.62x | 0.84x | 3.66x | - | 137M | |
| 10.76x | - | - | - | 126M | |
| -2x | 1.14x | 6.18x | - | 116M | |
| Average | 33.49x | 1.17x | 5.43x | 128.22M | ||
| Weighted average by Cap. | 55.23x | 1.07x | 5.08x |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- VEXT Stock
- Valuation Vext Science, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition